Only 36.4% of U.S. Adults Are Free of Cardiovascular Disease Risk Factors in Recent Years
A recent study shows that only 36.4% of U.S. adults had no cardiovascular disease risk factors from August 2021 to 2023, highlighting ongoing challenges in cardiovascular health and prevention.
Recent data from the National Center for Health Statistics reveals that only 36.4% of U.S. adults had no risk factors for cardiovascular disease (CVD) between August 2021 and August 2023. The study, led by Catharine A. Couch, Ph.D., R.D., evaluated the prevalence of common CVD risk factors such as uncontrolled high blood pressure, elevated blood lipids, poor blood glucose control, and high body mass index. Findings showed that while a little over one-third of adults had no risk factors, approximately 28.7% had two or more risk factors, increasing their likelihood of developing cardiovascular problems.
Men were more likely than women to have two or more CVD risk factors (31.7% versus 25.8%). As age increased, the percentage of adults with no CVD risk factors decreased, whereas the proportion with multiple risk factors grew. Additionally, socioeconomic status played a role, with adults from families earning 350% or more of the federal poverty level more likely to be free of risk factors and less likely to have multiple ones.
The data also indicates an upward trend in the prevalence of multiple risk factors compared to previous years. Monitoring these patterns is crucial for understanding the overall cardiovascular health of the U.S. population and guiding preventive strategies.
This analysis emphasizes the importance of ongoing public health efforts to reduce cardiovascular risk factors and promote healthier lifestyles among Americans.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Research Uncovers How Tirzepatide and Semaglutide Differ in Their Metabolic Effects
Animal studies reveal that tirzepatide temporarily increases energy expenditure, while semaglutide initially decreases it, offering new insights into obesity treatment mechanisms.
Enhancing Cancer Diagnosis Speed Through Connected Health Data
Advances in connected health data are paving the way for earlier and more reliable cancer diagnoses, transforming patient care and outcomes through comprehensive data analysis and system-wide improvements.
FDA Approves SetPoint Neuroimmune Modulation Device for Rheumatoid Arthritis
The FDA has approved the innovative SetPoint System, a neuroimmune device designed to activate the body's natural anti-inflammatory pathways for treating rheumatoid arthritis, offering hope for patients resistant to conventional therapies.
Exploring the Dual Impact of AI Scribes in Healthcare
An editorial in JMIR Medical Informatics explores the promising benefits and significant challenges of integrating AI scribes into healthcare, highlighting the need for careful, evidence-based implementation to ensure patient safety and clinician well-being.